Key result
MiECC during VT ablation allows effective volume management, reducing CVP to ~5 mmHg.
Why the study?
The advantages of mechanical assistance during ventricular tachycardia ablation have not been clinically demonstrated.
Does minimally invasive extra-corporeal circulation (MiECC) type III provide hemodynamic stability during VT ablation in patients with unresponsive VT?
Case Report (n=10)
No
Does minimally invasive extra-corporeal circulation (MiECC) type III provide hemodynamic stability during VT ablation in patients with unresponsive VT?
MiECC type III may provide effective hemodynamic support during VT ablation in high-risk patients, though further studies are needed.
May support hemodynamics in refractory VT ablation; hypothesis-generating, requires prospective trials before practice change.
BACKGROUND: The advantages of mechanical assistance during ventricular tachycardia (VT) ablation have not been clinically demonstrated. We propose and discuss a technique, set up by us, that makes use of minimally invasive extra-corporeal circulation (MiECC) type III associated with a venous reservoir system, which allows complete cardiac flow support and blood oxygenation as well as hemodynamic stability during long-lasting procedures. METHODS: We present a retrospective case series of ten patients with valvular heart disease and unresponsive Ventricular Tachycardia (VT) who underwent VT ablation with MiECC support. The mean age of the patients was 72 ± 8 years and the left ventricular ejection fraction was 36 ± 12%. All patients underwent a clinical evaluation to identify the cause of VT unresponsiveness (e.g., ischemic heart disease). RESULTS: A total of 140 min, the following parameters were evaluated and recorded for 140 min. Central venous pressure (CVP) was used to evaluate excess volume. During the first 5 min, the mean was 15 mmHg, with a pump flow of 1.5 L/min and a mean systemic arterial pressure of 100 mmHg while setting up the circulation support. Following drainage in a volumetric bag of 1 L of blood, CVP was reduced to a value of 5 mmHg with a flow rate of 5 L/min and a mean systemic arterial pressure of 65 mmHg. In the case of small and low-weight patients our "1 L protocol" can be modified. CONCLUSIONS: In this preliminary retrospective case series, the MiECC type III system may represent the ideal support system during VT ablation, and further studies are needed to support this preliminary report.
No takes yet. Share an insight, caveat, or question.
Ignazio Condello (2023) conducted a case report in Unresponsive Ventricular Tachycardia and Valvular Heart Disease (n=10). Minimally invasive extra-corporeal circulation (MiECC) type III was evaluated on Central venous pressure (CVP) after volume management. The use of a minimally invasive extra-corporeal circulation (MiECC) type III system during ventricular tachycardia ablation allowed effective blood volume management, reducing central venous pressure from 15 mmHg to 5 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: